IDYA in the 13F filings
Ideaya Biosciences Inc · CUSIP 45166A102
- Quarter end
- 30 Sep 2023
- the date the book describes
- Filed
- 14 Nov 2023
- latest of these filings; the earliest 13 Nov 2023
- Managers listing it
- 4
- at least, of 95 tracked, among listed positions
- Comparable managers
- 93
- filed both Q2 2023 and Q3 2023; 3 listed it in both
- Shares listed
- 4,373,389
- combined, among listed positions
- Reported value
- $118m
- combined, at the quarter end
Managers listing IDYA in Q3 2023
4 of 4 holders
| Action | Filing | |||||
|---|---|---|---|---|---|---|
| Janus Henderson Group Ltd | 1,723,160 | $47m | under 0.1% | Added | +55,637 | 14 Nov 2023 (the filing on sec.gov) |
| Capital Research Global Investors | 1,376,870 | $37m | under 0.1% | Added | +653,068 | 13 Nov 2023 (the filing on sec.gov) |
| Holocene Advisors LP | 1,032,931 | $28m | 0.12% | New | new | 14 Nov 2023 (the filing on sec.gov) |
| Woodline Partners LP | 240,428 | $6.5m | 0.08% | Added | +63,404 | 14 Nov 2023 (the filing on sec.gov) |
Largest increases and reductions, by shares
Increases
- Holocene Advisors LPnew position · 1,032,931 shares now+1,032,931
- Capital Research Global Investorsexisting position · 1,376,870 shares now+653,068
- Woodline Partners LPexisting position · 240,428 shares now+63,404
- Janus Henderson Group Ltdexisting position · 1,723,160 shares now+55,637
Reductions
No reduction among listed positions.
New positions and exits
New (1)
Exited (0)
No exit shown by a manager’s own filing.
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2020 | 1 | $14m | n.a. | n.a. |
| Q3 2020 | 1 | $15m | n.a. | n.a. |
| Q4 2020 | 1 | $16m | n.a. | n.a. |
| Q1 2021 | 3 | $31m | n.a. | n.a. |
| Q2 2021 | 3 | $26m | n.a. | n.a. |
| Q3 2021 | 3 | $37m | n.a. | n.a. |
| Q4 2021 | 3 | $50m | n.a. | n.a. |
| Q1 2022 | 1 | $21m | n.a. | n.a. |
| Q2 2022 | 1 | $21m | n.a. | n.a. |
| Q2 2023 | 3 | $60m | n.a. | n.a. |
| Q3 2023 | 4 | $118m | n.a. | n.a. |
| Q4 2023 | 5 | $275m | 5 | 0 |
| Q1 2024 | 10 | $1.0bn | 8 | 1 |
| Q2 2024 | 8 | $479m | 6 | 3 |
| Q3 2024 | 6 | $309m | 5 | 1 |
| Q4 2024 | 5 | $245m | 3 | 2 |
| Q1 2025 | 3 | $159m | 2 | 1 |
| Q2 2025 | 3 | $374m | 2 | 1 |
| Q3 2025 | 4 | $458m | 2 | 1 |
| Q4 2025 | 3 | $495m | 14 | 13 |
| Q1 2026 | 2 | $414m | 11 | 14 |
| Q2 2026 | 3 | $533m | 16 | 10 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
IDYA and LLY →IDYA and JNJ →IDYA and VRTX →Choose a stock to compare with IDYA →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own IDYA, latest filings →Back to the 13F Explorer →